145 Effect of scheduling on clinical efficacy of amrubicin (SM-5887) in patients with advanced non-small cell lung cancer (NSCLC): Single injection (the SM-5887 lung cancer study group) versus 3 consecutive day injection (the West Japan lung cancer group)

✍ Scribed by Hida, T.; Sugiura, T.; Ikegami, H.; Kimura, I.; Ariyoshi, Y.

• Book ID: 122481457
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 146 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)89422-6